research The Prevalence of Metabolic Syndrome in Male Patients of Early Onset Androgenic Alopecia Compared to Age-Matched Controls
Men with early-onset hair loss have a higher risk of metabolic syndrome.
Search
for
Did you mean Early-Onset Androgenic Alopecia?
Products matching "early androgenic alopecia"
Tracking 3 products like 151 Tugain 5 Solution (Minoxidil 5%), 178 Hair4u 10% and 179 Tugain 5% 60ml from by companies like Inhouse Pharmacy and ReliableRxpharmacy. View all 3 products »
Sort by
Research
30 / 1000+ resultsresearch Evaluation of Serum Amyloid A3 in Young Adult Males with Early Onset of Androgenic Alopecia
Young men with early hair loss and high SAA3 levels are at higher risk for heart disease.
research Topical Minoxidil Therapy for Androgenic Alopecia in the Middle East
Topical minoxidil is effective and safe for hair regrowth in Middle Eastern men with early baldness, with better results in younger patients and certain types of baldness.
research Current Issues on the Genetic Implications and Treatment of Androgenic Alopecia
Hair loss is linked to heart disease and metabolic syndrome, and while current treatments vary in effectiveness, more research is needed for better solutions.
research A Systematic Review and Meta-Analysis on the Association Between Androgenic Alopecia and the Risk of Metabolic Syndrome
People with androgenic alopecia (AGA) have a higher chance of getting metabolic syndrome.
research Skin Features in Myotonic Dystrophy Type 1: An Observational Study
People with Myotonic Dystrophy type 1 are more likely to have certain skin conditions, but not more likely to get skin cancer.
research Dermoscopy in Female Androgenic Alopecia: Method Standardization and Diagnostic Criteria
Trichoscopy can diagnose female hair loss with high accuracy by looking for specific patterns in hair and scalp appearance.
research Trichoscopy Criteria for Diagnosing Female Androgenic Alopecia
Trichoscopy is a useful non-invasive method to diagnose female hair loss with high accuracy.
research Androgenic Alopecia and Insulin Resistance: Are They Really Related?
There is no significant link between male pattern baldness and insulin resistance.
research Early Androgenetic Alopecia as a Predictor of Ischemic Heart Disease
Early hair loss may predict heart disease.
research Natural Scalp Hair Regression in Preclinical Stages of Male Androgenetic Alopecia and Its Reversal by Finasteride
Finasteride reverses early hair loss and promotes growth.
research Topical Minoxidil for Hair Regrowth
5% minoxidil helps hair regrowth in androgenic alopecia.
research Hair Loss, Insulin Resistance, and Heredity in Middle-Aged Women: A Population-Based Study
Hair loss in middle-aged women is often linked to insulin resistance and a family history of hair loss, particularly from their fathers.
research Australian Trial of Topical Minoxidil and Placebo in Early Male Pattern Baldness
Minoxidil modestly increases hair growth in men with early baldness and is safe to use.
research Male Pattern Androgenetic Alopecia
Androgens contribute to common male hair loss; more research needed for hair growth medication.
research Finasteride in the Treatment of Androgenetic Alopecia
Finasteride effectively treats male pattern baldness, improving hair growth and density.
research An Analysis of Gene Expression Data Involving Examination of Signaling Pathways Activation Reveals New Insights into the Mechanism of Action of Minoxidil Topical Foam in Men with Androgenetic Alopecia
Minoxidil foam helps hair growth by increasing good proteins and decreasing bad pathways in men with hair loss.
research Efficacy and Safety of a Novel Herbal Solution for the Treatment of Androgenetic Alopecia and Comparison with 5% Minoxidil: A Double-Blind, Randomized Controlled Trial Study
Herbal solution improves hair diameter and density more than 5% minoxidil for androgenetic alopecia.
research The Association Between Metabolic Syndrome Components and Hair Loss in Both Male and Female Individuals
Hair loss may signal metabolic problems and increased risk of heart disease, suggesting people with hair loss should be checked for these issues.
research Combination and Rotational Therapy in Androgenetic Alopecia
Using different hair loss treatments at various times can improve results and reduce side effects for people with chronic hair loss.
research A Patient With Combined Polycystic Ovary Syndrome And Autoimmune Polyglandular Syndrome Type 2
A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.
research Myotonic Dystrophy Type 1: Enhancing Patient Management Through Genetic and Multisystem Studies
There is no cure for myotonic dystrophy type 1, so treatment focuses on managing symptoms and complications.
research Female Pattern Hair Loss
Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.
research Trichoscopy in the Healthy Female: Method Standardization and Norms for Measurable Parameters
Researchers established normal hair and scalp characteristics for healthy women using trichoscopy.
research Cutaneous Neoplasms in Myotonic Dystrophy Type 1
People with myotonic dystrophy type 1 tend to develop basal cell carcinoma at a younger age but not more frequently than others.
research Female Pattern Hair Loss
Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.
research Low Iron Level Is Related to Telogen Effluvium in Women: A Case-Control Study
Low iron levels are linked to hair loss in women.
research The Skin and Subcutaneous Tissues: Conditions, Diagnosis, and Systemic Implications
The document concludes that skin and nail changes can indicate various underlying health conditions.
research Female Pattern Hair Loss
research Multiple Hemangiomas of the Tongue and Oral Cavity in a Myotonic Dystrophy Type 1 Patient: A Case Report
A patient with Myotonic dystrophy type 1 had multiple tongue hemangiomas and was sensitive to anesthesia.